The Association of Clinical Research Professionals secured a Bronze in the Health: Global Awareness category at the 5th Anthem Awards for its 2025 Clinical Trials Day campaign, “Powered by Purpose,” selected from more than 2,000 submissions across 42 countries. The effort drew broad engagement as thousands of clinical research professionals shared stories and organized workplace activations around the annual May 20 observance.
The core news is straightforward: an external, cross-industry awards body recognized ACRP’s workforce-focused campaign at a time when the research ecosystem is managing attrition, budget pullbacks, and sustained hiring pressure. Clinical Trials Day has been ACRP’s signature platform since 2014; this year’s iteration leaned into personal narratives to reinforce professional identity and spotlight participant contributions.
Strategically, the move functions as a retention and pipeline play under the banner of recognition. In a year marked by staff reductions and constrained operating budgets at sites and sponsors, ACRP is doubling down on owning the profession’s story and creating a rallying point that transcends individual organizations. The Anthem Award lends credibility outside of life sciences and signals to corporate partners, foundations, and consumer-facing brands that clinical research can compete for mainstream attention. That matters because the workforce problem is no longer simply a staffing challenge; it is a reputational and cultural one that influences whether early-career clinicians and data talent see research as a stable, purposeful path. Framing the field in the language of purpose is an intentional counter to headlines about burnout, administrative burden, and protocol complexity.
For sponsors and CROs, the recognition offers a ready-made employer branding and engagement moment that can be leveraged without heavy lift: aligning internal communications, amplifying staff stories, and linking recognition to professional development budgets. Sites, especially those operating with thin margins, gain a low-cost mechanism to boost morale and cohesion, which can translate to steadier enrollment performance and fewer quality knock-ons from turnover. Vendors can tie product education and user communities to Clinical Trials Day to reinforce training and adoption, while regulators and funders may see the campaign as aligned with broader policy goals around professionalization, competency frameworks, and workforce diversity. The softer benefits—community trust and participant goodwill—touch trial execution directly, given ongoing accrual challenges and heightened scrutiny of patient experience.
The next test is conversion from awareness to measurable workforce outcomes. Indicators to watch include growth in ACRP credentialing uptake, participation in apprenticeships or standardized competency programs, and retention metrics within participating organizations around the May–June window. Another signal will be whether major sponsors and CROs formalize co-branded initiatives in 2026, moving beyond social amplification to funded scholarships, backfill support for training time, or embedded recognition within performance frameworks. If Anthem visibility unlocks cross-sector partners, it could diversify funding streams for workforce development beyond the traditional life sciences budget cycle. The risks are familiar: symbolic campaigns that do not alter hiring pipelines, social media fatigue that blunts year-over-year impact, and continued budget tightening that sidelines training line items. The opportunity is to treat Clinical Trials Day as a catalyst for a more durable workforce strategy—one that links purpose messaging to concrete supports that keep coordinators, CRAs, and investigators in the field and brings new entrants into it.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
